Refine Search
(122)
(200)
(508)
(530)

Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H1 2019’, provides an overview of the Chemotherapy Induced Nausea and Vomiting pipeline landscape.

The report provides comprehensive information on the...

Spinal Muscular Atrophy (SMA) - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Spinal Muscular Atrophy (SMA) - Pipeline Review, H1 2019’, provides an overview of the Spinal Muscular Atrophy (SMA) pipeline landscape.

The report provides comprehensive information on the therapeutics under de...

Osteoarthritis - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Osteoarthritis - Pipeline Review, H1 2019’, provides an overview of the Osteoarthritis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Osteoarthritis, ...

Polycythemia Vera - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Polycythemia Vera - Pipeline Review, H1 2019’, provides an overview of the Polycythemia Vera pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Polycythem...

Fibrosarcoma - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Fibrosarcoma - Pipeline Review, H1 2019’, provides an overview of the Fibrosarcoma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Fibrosarcoma, comple...

Crohn's Disease (Regional Enteritis) - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Crohn's Disease (Regional Enteritis) - Pipeline Review, H1 2019’, provides an overview of the Crohn's Disease (Regional Enteritis) pipeline landscape.

The report provides comprehensive information on the...

Osteosarcoma - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Osteosarcoma - Pipeline Review, H1 2019’, provides an overview of the Osteosarcoma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Osteosarcoma, comple...

Nasopharyngeal Cancer - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Nasopharyngeal Cancer - Pipeline Review, H1 2019’, provides an overview of the Nasopharyngeal Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Na...

Diabetic Macular Edema - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Diabetic Macular Edema - Pipeline Review, H1 2019’, provides an overview of the Diabetic Macular Edema pipeline landscape.

The report provides comprehensive information on the therapeutics under development for ...

Sepsis - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Sepsis - Pipeline Review, H1 2019’, provides an overview of the Sepsis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Sepsis, complete with analysis b...

Community Acquired Pneumonia - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Community Acquired Pneumonia - Pipeline Review, H1 2019’, provides an overview of the Community Acquired Pneumonia pipeline landscape.

The report provides comprehensive information on the therapeutics under deve...

Systemic Sclerosis (Scleroderma) - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Systemic Sclerosis (Scleroderma) - Pipeline Review, H1 2019’, provides an overview of the Systemic Sclerosis (Scleroderma) pipeline landscape.

The report provides comprehensive information on the therapeutics un...

Diabetic Peripheral Neuropathy - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Diabetic Peripheral Neuropathy - Pipeline Review, H1 2019’, provides an overview of the Diabetic Peripheral Neuropathy pipeline landscape.

The report provides comprehensive information on the therapeutics under ...

Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H1 2019

  • $2,500
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H1 2019’, provides an overview of the Acute Renal Failure (ARF) (Acute Kidney Injury) pipeline landscape.

The report provides comprehensive info...

Arrhythmias - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Arrhythmias - Pipeline Review, H1 2019’, provides an overview of the Arrhythmias pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Arrhythmias, complete ...